MS, Senior Director of Antibody R&D
Mr. Song Li, our Senior Director of R&D, has over 10 years of experience in antibody drug discovery and process development. He has led the drug discovery and pre-clinical development of our IND-approved drug candidates. Mr. Li possesses solid expertise in lead selection, antibody engineering and optimization, cell line and process development and antibody characterization. Prior to joining us, he was a manager at Huabo Biopharm. Mr. Li holds 10 issued patents and 44 patent applications.
Since 2015, he has been working as the R&D Director of Immuneonco, and is responsible for the research and development of the company's compound pipeline.